Sort   by:  
 Page size 
UnknownEfficacy and Safety of Apremilast in the Treatment of Patients with Mild-to-Moderate Psoriasis in Japan: Results from PROMINENT, A Phase 3b, Open-Label, Single-Arm Study.
Not available
S-EPMC9209617 | biostudies-literature
UnknownEfficacy and Safety of Bimekizumab in Japanese Patients with Generalised Pustular Psoriasis and Erythrodermic Psoriasis: 3-Year Results from BE BRIGHT, a Multicentre, Open-Label, Phase 3 Study.
Not available
S-EPMC12454709 | biostudies-literature
Sort   by:  
 Page size